4//SEC Filing
PETKANAS DEAN 4
Accession 0001607062-21-000244
CIK 0001615999other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 8:04 AM ET
Size
5.8 KB
Accession
0001607062-21-000244
Insider Transaction Report
Form 4
PETKANAS DEAN
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2021-07-29$0.05/sh+1,875,000$90,000→ 24,859,029 total(indirect: See Note)
Footnotes (2)
- [F1]The reporting person agreed to accept 1,875,000 restricted shares of the issuers common stock in exchange for the discharge of an aggregate of $90,000 of accrued but unpaid monies payable by the issuer to the reporting person as a portion of his salary. The issuance was completed on July 29, 2021. The price of the shares acquired by the reporting person is equal to the closing price of the Company's common stock on July 28, 2021, which was $0.048 per share.
- [F2]Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
Documents
Issuer
NEUROPATHIX, INC.
CIK 0001615999
Entity typeother
Related Parties
1- filerCIK 0000944235
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 8:04 AM ET
- Size
- 5.8 KB